DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Nowicki M, Rychlik I, Haller H et al.
Long-Term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairmant: a randomised controlled 52-week efficacy and safety study.
Int J Clin Pract 2011;
65: 1230-1239
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.